Compare INSM & CINF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INSM | CINF |
|---|---|---|
| Founded | 1988 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 25.0B |
| IPO Year | 2000 | 1994 |
| Metric | INSM | CINF |
|---|---|---|
| Price | $162.30 | $158.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 4 |
| Target Price | ★ $200.48 | $177.25 |
| AVG Volume (30 Days) | ★ 2.1M | 559.5K |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | N/A | ★ 4.40 |
| EPS | N/A | ★ 15.17 |
| Revenue | N/A | ★ $12,631,000,000.00 |
| Revenue This Year | $174.73 | N/A |
| Revenue Next Year | $65.13 | $6.97 |
| P/E Ratio | ★ N/A | $10.41 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $60.40 | $123.02 |
| 52 Week High | $212.75 | $174.27 |
| Indicator | INSM | CINF |
|---|---|---|
| Relative Strength Index (RSI) | 60.93 | 46.13 |
| Support Level | $157.91 | $150.83 |
| Resistance Level | $167.01 | $168.35 |
| Average True Range (ATR) | 6.19 | 3.33 |
| MACD | 3.01 | -0.20 |
| Stochastic Oscillator | 84.92 | 33.47 |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.